StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Maxim Group Downgrades Vertex (VRTX) to Hold
February 6, 2019 7:45 AM
Maxim Group analyst Jason McCarthy downgraded Vertex (NASDAQ: VRTX) from Buy to Hold.The analyst highlighted:Vertex reported 4Q18 with cystic fibrosis ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
Vertex (VRTX) PT Raised to $234 at BMO Capital
February 6, 2019 7:53 AM
Vertex (VRTX) PT Raised to $220 at Cowen
February 6, 2019 7:52 AM
Vertex (VRTX) PT Lowered to $213 at RBC Capital
February 6, 2019 7:14 AM
Vertex (VRTX) PT Raised to $200 at UBS
February 6, 2019 6:32 AM
Vertex (VRTX) PT Raised to $216 at JMP Securities
February 6, 2019 4:13 AM
Vertex (VRTX) PT Raised to $218 at Piper Jaffray
February 6, 2019 1:57 AM
Form 8-K VERTEX PHARMACEUTICALS For: Feb 05
February 5, 2019 4:17 PM
Vertex Pharma (VRTX) Tops Q4 EPS by 24c, Revenues Beat; Offers FY19 Revenue Guidance
February 5, 2019 4:03 PM
Vertex Reports Full-Year and Fourth-Quarter 2018 Financial Results
February 5, 2019 4:01 PM
